Roxadustat Promise for Oral Treatment of Anemia in Kidney Disease ...Middle East

Medscape - News
Headed to an FDA advisory committee assessment this summer, the oral anemia drug roxadustat, from the novel HIF-PHI drug class, adds to its efficacy and safety track record. Medscape Medical News

Hence then, the article about roxadustat promise for oral treatment of anemia in kidney disease was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Roxadustat Promise for Oral Treatment of Anemia in Kidney Disease )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News